MedPath

Study on the clinical effect evaluation of Chinese patent medicine combined regimen for adenomyosis

Not Applicable
Recruiting
Conditions
Adenomyosis
Registration Number
ITMCTR2000002910
Lead Sponsor
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) meet the clinical diagnostic criteria of adenomyosis;
(2) meet the diagnosis criteria of TCM syndromes;
(3) aged >= 25 and <= 50;
(4) patients who have not used any drugs with serious effects on liver and kidney function within 3 months;
(5) those who voluntarily participate in the study and sign the informed consent.

Exclusion Criteria

(1) primary dysmenorrhea, genital cancer or other local or systemic malignant tumors;
(2) patients with serious diseases of cardiovascular, cerebrovascular, liver, kidney or hematopoietic system;
(3) the introduction period of the case was not suitable for the author, or the case was combined with mental or neurological diseases and could not be cooperated;
(4) women who are pregnant or planning to be pregnant recently.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Menstrual volume rating table;visual analogue scale (VAS);
Secondary Outcome Measures
NameTimeMethod
Transvaginal gynecological ultrasound;TCM syndrome score table;Serum CA125;
© Copyright 2025. All Rights Reserved by MedPath